Kbc Group Nv Ptc Therapeutics, Inc. Transaction History
Kbc Group Nv
- $36.3 Billion
- Q4 2024
A detailed history of Kbc Group Nv transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 3,045 shares of PTCT stock, worth $155,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,045
Previous 2,232
36.42%
Holding current value
$155,173
Previous $83,000
65.06%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PTCT
# of Institutions
257Shares Held
77.3MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$468 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$396 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$377 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$325 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$244 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.65B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...